Literature DB >> 2391695

Approaches to isozyme-specific inhibitors. 17. Attachment of a selectivity-inducing substituent to a multisubstrate adduct. Implications for facilitated design of potent, isozyme-selective inhibitors.

F Kappler1, A Hampton.   

Abstract

The synthesis is described of a methyl-C5' adduct of L-methionine and beta,gamma-ATP bearing a 6-S-n-Bu group in place of the 6-NH2 group of the parent adduct. The latter is a potent multisubstrate inhibitor in a model system consisting of the M-2 and M-T isozymes of rat methionine adenosyltransferase. When attached to ATP, the 6-S-n-Bu group induces selectivity for M-T inhibition by elevating affinity for the ATP site of M-T but not of M-2. In the above adduct it exerted a similar effect, expressed by selectivity and increased inhibitory potency toward M-T. This affords a second illustration of the ability of this approach to generate, relatively readily, a potent inhibitor with moderate isozyme selectivity. An overview is given of extensive evidence from the present series of studies that moderate (ca. 10-fold) isozyme selectivity is often exhibited by substrate derivatives bearing a single short substituent at a variety of atoms. This, together with features of another feasible approach to isozyme-selective inhibitor design, suggests an approach that has potential to facilitate the design of potent inhibitors that are both isozyme-selective and selective for a given metabolic conversion. It comprises (1) evaluation of the above type of substrate derivatives as inhibitors of a chemotherapeutically significant set of isozymes (target and nontarget), (2) attempted derivation of a potent multisubstrate adduct inhibitor of the isozymes, (3) attachment to such an adduct of one or more selectivity-inducing substituents revealed in the first step, and, if desired, (4) systematic modification of substituents with a view to obtaining enhanced potency and/or isozyme-selectivity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2391695     DOI: 10.1021/jm00171a032

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  A neoceptor approach to unraveling microscopic interactions between the human A2A adenosine receptor and its agonists.

Authors:  Kenneth A Jacobson; Michihiro Ohno; Heng T Duong; Soo-Kyung Kim; Susanna Tchilibon; Michal Cesnek; Antonín Holý; Zhan-Guo Gao
Journal:  Chem Biol       Date:  2005-02

2.  Discovery of novel types of inhibitors of S-adenosylmethionine synthesis by virtual screening.

Authors:  John C Taylor; Charles W Bock; Fusao Takusagawa; George D Markham
Journal:  J Med Chem       Date:  2009-10-08       Impact factor: 7.446

3.  A facile synthesis of 5'-fluoro-5'-deoxyacadesine (5'-F-AICAR): a novel non-phosphorylable AICAR analogue.

Authors:  Stefano D'Errico; Giorgia Oliviero; Nicola Borbone; Jussara Amato; Daniele D'Alonzo; Vincenzo Piccialli; Luciano Mayol; Gennaro Piccialli
Journal:  Molecules       Date:  2012-11-02       Impact factor: 4.411

4.  Synthesis and biological evaluation of nucleoside analogues having 6-chloropurine as anti-SARS-CoV agents.

Authors:  Masahiro Ikejiri; Masayuki Saijo; Shigeru Morikawa; Shuetsu Fukushi; Tetsuya Mizutani; Ichiro Kurane; Tokumi Maruyama
Journal:  Bioorg Med Chem Lett       Date:  2007-02-13       Impact factor: 2.823

5.  Characterisation of methionine adenosyltransferase from Mycobacterium smegmatis and M. tuberculosis.

Authors:  Bradley J Berger; Marvin H Knodel
Journal:  BMC Microbiol       Date:  2003-06-16       Impact factor: 3.605

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.